Archive \ Volume.13 2022 Issue 4

Vaccine Prevention of Tuberculosis in Children: Outstanding Issues Family Medicine Systems in Ukraine

Krychkovska Aelita, Konechna Roksolana, Bolibrukh Liliia, Lopatynska Oksana
Abstract

The main aspects of the problems of childhood vaccination in Ukraine are studied and the ways of their solution are presented. The results of the survey on the degree of awareness of parents and future parents about the feasibility of vaccination in childhood and determining the main reason for refusal of vaccination are presented and analyzed. A SWOT analysis was conducted and the strengths and weaknesses, advantages and disadvantages of the process of children’s vaccination in the opinion of their parents or future parents were defined. We have also established strategies: creation and implementation of preliminary express analyzes for vaccine tolerability; creation of an online vaccination schedule or a special application with notifications about vaccination dates individually for each child; development of a high-quality system of free vaccination and raising the level of information and sanitary and educational work of medical (pharmaceutical) institutions; increasing the responsibility of parents for refusing to vaccinate a child; a strategy for ensuring the availability of quality vaccines at the state level. The dynamics of tuberculosis incidence have been established and a study of the availability of anti-tuberculosis vaccines in the pharmaceutical market of Ukraine has been conducted. Understanding the social problems faced by the patient can help not only to solve some of them but also to consciously approach the need for vaccination and revaccination of children.



How to cite:
Vancouver
Aelita K, Roksolana K, Liliia B, Oksana L. Vaccine Prevention of Tuberculosis in Children: Outstanding Issues Family Medicine Systems in Ukraine. Arch Pharm Pract. 2022;13(4):17-23. https://doi.org/10.51847/OMcaXT87jE
APA
Aelita, K., Roksolana, K., Liliia, B., & Oksana, L. (2022). Vaccine Prevention of Tuberculosis in Children: Outstanding Issues Family Medicine Systems in Ukraine. Archives of Pharmacy Practice, 13(4), 17-23. https://doi.org/10.51847/OMcaXT87jE

Download Citation
References

1.      Order of the Ministry of Health of Ukraine dated 11.11.2021 No. 2506 "On approval of the Amendments to the Regulation on the organization and implementation of vaccination prevention, the Procedure for ensuring proper conditions of storage, transportation, use, and vaccination, accounting for toxoids and allergen for tuberculosis: https://alergova.ua/zakon.rada.gov.ua/laws/show/z1527-21# Text

2.      Order of the Ministry of Health of Ukraine dated May 18, 2018 No. 947 "On Amendments to the Calendar of Preventive Vaccinations in Ukraine" - Access mode: https://zakon.rada.gov.ua/laws/show/z0659-18#Text

3.      Order of the Ministry of Health of Ukraine dated July 3, 2020 No. 1510 "Changes to the calendar of preventive vaccinations in Ukraine" - Access mode: https://zakon.rada.gov.ua/laws/show/z1013-20#Text

4.      The situation with tuberculosis in Ukraine during the period of health care reform [Electronic resource] / Yu.V. I. Feshchenko, V. M. Melnyk, V. G. Matusevich. – Access mode: http://amnu.gov.ua/sytuacziya-z-tuberkulozu-v-ukrayini-v-period-reformuvannya-ohorony-zdorov-ya/

5.      Analytical and statistical materials on TV. [Electronic resource] Access mode: https://phc.org.ua/kontrol-zakhvoryuvan/tuberkuloz/ statistika-z-tb/analitichno-statistichni-materiali-z-tbIn Ukraine, the National Calendar of preventive vaccinations has been updated. [Electronic resource] Access mode: https://moz.gov.ua/article/ news/v-ukraini-onovleno-nacionalnij-kalendar-profilaktichnih-scheplen2018

6.        Law of Ukraine "On Ensuring Sanitary and Epidemic Welfare of the Population" dated 24.02.1994 No. 4004-XII, as amended from 14.01.2021. Access mode:

https://zakon.rada.gov.ua/laws/show/4004-12#Text

7.        Global research on coronavirus disease (COVID-19). Available from: https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov

8.        Casey MF, Price L, Markwalter D, Bohrmann T, Tsujimoto TM, Lavin K, et al. Advance Care Planning for Emergency Department Patients with COVID-19 Infection: An Assessment of a Physician Training Program. Am J Hosp Palliat Care. 2022:10499091211072850. doi:10.1177/10499091211072850

9.        European Commission, Directorate-General for Communication, The EU and the Coronavirus pandemic, 2022. Available from: https://data.europa.eu/doi/10.2775/401085

10.      Ustinov AV. Tuberculosis in Ukraine: equal morbidity is decreasing. Morion Publishing House [Electronic resource] Access mode: https://www.umj.com.ua/article/139407/tuberkuloz-v-ukrayini-riven-zahvoryuvanosti-znizhuyetsya

11.      State Register of Medicinal Products of Ukraine. Available from: http://www.drlz.com.ua/

12.      Wu Q, Dudley MZ, Chen X, Bai X, Dong K, Zhuang T, et al. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Med. 2021;19(1):1-6. doi:10.1186/s12916-021-02059-5

13.      Walach H, Klement RJ, Aukema W. The safety of covid-19 vaccinations—we should rethink the policy. Vaccines. 2021;9(7):693. doi:10.3390/vaccines9070693

14.      Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. Nat Med. 2021;27(8):1338-9. doi:10.1038/s41591-021-01459-7

15.      Freitas BC, Meneguello JE, Eugenio LG, Lemos R, Scodro RB, Siqueira VL, et al. Cord factor producer Mycobacterium abscessus subsp. bolletii in asymptomatic immunocompetent host sputa samples. Braz J Pharm Sci. 2022;58. doi:10.1590/s2175-97902022e19504  

16.      Ibnouf EO, Elegami AA, Waggiallah HA. The Effect of Some Sudanese Medicinal Plant Extracts on Some Clinically Isolated Pulmonary Tuberculosis Bacteria. Int J Pharm Phytopharmacol Res. 2021;11(2):31-7. doi:10.51847/wvOdR4Dgl5 

17.      Pulingam T, Parumasivam T, Gazzali AM, Sulaiman AM, Chee JY, Lakshmanan M, et al. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci. 2021:106103. doi:10.1016/j.ejps.2021.106103

18.      Firouzi Z, Jaafari MR, Sankian M, Zare S, Tafaghodi M. A novel nanomicelle composed from PEGylated TB di-peptide could be successfully used as a BCG booster. Iran J Basic Med Sci. 2022;25(2):223-31.

19.      Garg NK, Dwivedi P, Jain A, Tyagi S, Sahu T, Tyagi RK. Development of novel carrier (s) mediated tuberculosis vaccine: More than a tour de force. Eur J Pharm Sci. 2014;62:227-42. doi:10.1016/j.ejps.2014.05.028